Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,171 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Calibrating Hepatitis E Virus Serological Assays Using Asymptomatic Specimens Obtained in Japan.
Terahara K, Li TC, Matsubayashi K, Sakata H, Kato T, Naganuma A, Ogawa K, Honda K, Itakura J, Akutsu N, Tobita H, Korenaga M, Kanto T, Sugiyama R, Suzuki R, Hamaguchi I, Isogawa M, Takahashi Y. Terahara K, et al. Among authors: takahashi y. Microbiol Spectr. 2022 Oct 26;10(5):e0214622. doi: 10.1128/spectrum.02146-22. Epub 2022 Sep 20. Microbiol Spectr. 2022. PMID: 36125314 Free PMC article.
Identification of Two Critical Neutralizing Epitopes in the Receptor Binding Domain of Hepatitis B Virus preS1.
Yato K, Onodera T, Matsuda M, Moriyama S, Fujimoto A, Watashi K, Aizaki H, Tanaka T, Moriishi K, Nishitsuji H, Shimotohno K, Tamura K, Takahashi Y, Wakita T, Muramatsu M, Kato T, Suzuki R. Yato K, et al. Among authors: takahashi y. J Virol. 2021 Mar 1;95(5):e01680-20. doi: 10.1128/JVI.01680-20. Epub 2020 Dec 9. J Virol. 2021. PMID: 33298539 Free PMC article.
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants.
Moriyama S, Adachi Y, Sato T, Tonouchi K, Sun L, Fukushi S, Yamada S, Kinoshita H, Nojima K, Kanno T, Tobiume M, Ishijima K, Kuroda Y, Park ES, Onodera T, Matsumura T, Takano T, Terahara K, Isogawa M, Nishiyama A, Kawana-Tachikawa A, Shinkai M, Tachikawa N, Nakamura S, Okai T, Okuma K, Matano T, Fujimoto T, Maeda K, Ohnishi M, Wakita T, Suzuki T, Takahashi Y. Moriyama S, et al. Among authors: takahashi y. Immunity. 2021 Aug 10;54(8):1841-1852.e4. doi: 10.1016/j.immuni.2021.06.015. Epub 2021 Jul 2. Immunity. 2021. PMID: 34246326 Free PMC article.
SARS-CoV-2 Omicron-neutralizing memory B cells are elicited by two doses of BNT162b2 mRNA vaccine.
Kotaki R, Adachi Y, Moriyama S, Onodera T, Fukushi S, Nagakura T, Tonouchi K, Terahara K, Sun L, Takano T, Nishiyama A, Shinkai M, Oba K, Nakamura-Uchiyama F, Shimizu H, Suzuki T, Matsumura T, Isogawa M, Takahashi Y. Kotaki R, et al. Among authors: takahashi y. Sci Immunol. 2022 Apr 22;7(70):eabn8590. doi: 10.1126/sciimmunol.abn8590. Epub 2022 Apr 22. Sci Immunol. 2022. PMID: 35113654 Free PMC article.
Distinct immune cell dynamics correlate with the immunogenicity and reactogenicity of SARS-CoV-2 mRNA vaccine.
Takano T, Morikawa M, Adachi Y, Kabasawa K, Sax N, Moriyama S, Sun L, Isogawa M, Nishiyama A, Onodera T, Terahara K, Tonouchi K, Nishimura M, Tomii K, Yamashita K, Matsumura T, Shinkai M, Takahashi Y. Takano T, et al. Among authors: takahashi y. Cell Rep Med. 2022 May 17;3(5):100631. doi: 10.1016/j.xcrm.2022.100631. Epub 2022 Apr 22. Cell Rep Med. 2022. PMID: 35545084 Free PMC article.
Safety and immunogenicity of the Pfizer/BioNTech SARS-CoV-2 mRNA third booster vaccine dose against the BA.1 and BA.2 Omicron variants.
Seki Y, Yoshihara Y, Nojima K, Momose H, Fukushi S, Moriyama S, Wagatsuma A, Numata N, Sasaki K, Kuzuoka T, Yato Y, Takahashi Y, Maeda K, Suzuki T, Mizukami T, Hamaguchi I. Seki Y, et al. Among authors: takahashi y. Med. 2022 Jun 10;3(6):406-421.e4. doi: 10.1016/j.medj.2022.04.013. Epub 2022 Apr 26. Med. 2022. PMID: 35815933 Free PMC article.
SARS-CoV-2-specific CD4+ T cell longevity correlates with Th17-like phenotype.
Terahara K, Sato T, Adachi Y, Tonouchi K, Onodera T, Moriyama S, Sun L, Takano T, Nishiyama A, Kawana-Tachikawa A, Matano T, Matsumura T, Shinkai M, Isogawa M, Takahashi Y. Terahara K, et al. Among authors: takahashi y. iScience. 2022 Sep 16;25(9):104959. doi: 10.1016/j.isci.2022.104959. Epub 2022 Aug 17. iScience. 2022. PMID: 35992306 Free PMC article.
Neutralization of hepatitis B virus with vaccine-escape mutations by hepatitis B vaccine with large-HBs antigen.
Washizaki A, Murayama A, Murata M, Kiyohara T, Yato K, Yamada N, Aly HH, Tanaka T, Moriishi K, Nishitsuji H, Shimotohno K, Goh Y, Ishii KJ, Yotsuyanagi H, Muramatsu M, Ishii K, Takahashi Y, Suzuki R, Akari H, Kato T. Washizaki A, et al. Among authors: takahashi y. Nat Commun. 2022 Sep 5;13(1):5207. doi: 10.1038/s41467-022-32910-z. Nat Commun. 2022. PMID: 36064848 Free PMC article.
12,171 results
You have reached the last available page of results. Please see the User Guide for more information.